Silymarin mediated differential modulation of toxicity induced by carbon tetrachloride, paracetamol and D-galactosamine in freshly isolated rat hepatocytes

Indian Journal of Experimental Biology

Volumn 35, Issue 6, 1997, Pages 611-617

  Chrungoo, Vir Ji ^a   Singh, Kuldip ^a   Singh, Jaswant ^a  

^a CSIR INDIAN INSTITUTE OF INTEGRATIVE MEDICINE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

3 METHYLCHOLANTHRENE; CARBON TETRACHLORIDE; GALACTOSAMINE; GLUTATHIONE; PARACETAMOL; SILYMARIN; URIDINE DIPHOSPHATE GLUCURONIC ACID;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CELL SUSPENSION; CONTROLLED STUDY; CYTOTOXICITY TEST; DRUG EFFECT; DRUG SCREENING; LIPID PEROXIDATION; LIVER CELL CULTURE; LIVER TOXICITY; MALE; NONHUMAN; RAT;

ACETAMINOPHEN; ANALGESICS, NON-NARCOTIC; ANIMALS; CARBON TETRACHLORIDE POISONING; DRUG EVALUATION, PRECLINICAL; GALACTOSAMINE; GUINEA PIGS; LIVER; MALE; RATS; SILYMARIN;

ANIMALIA;

EID: 0030772332     PISSN: 00195189     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Wagner H, Seligmann O & Lotter H, In: Flavonoids and Bioflavonoids, 1985, Eds. L. Farkas, M. Gabor and F. Kellay, p.139.
2. Salmi A & Sarna A, Scand J Gastroenterol, 17 (1982) 517.
3. Trinchet JC, Coste T, Levy UG, Vivet F, Duchatelle V, Legendre C, Gotheil C & Beaugrand M, Gasteroenterol. Clin Biol, 13 (1989) 120.
4. Letteron P, Labbe G, Degott C, Berson A, Fromenty B, DeLaforge M, Larrey D & Pessayre D, Biochem Pharmacol, 39, (1990) 2027.
5. Mourelle, M, Murrel P, Favari L & Franco T, Find Clin Pharmacol, 3 (1989) 183.
6. Hikino H, Kiso Y, Wagner H & Fiebig M, Planta Med, 50 (1984) 248.
7. Bosisio E., Benelli C and Pirola O, Pharm Res, 25 (1992) 147.
8. Chrungoo VJ., Singh K & Singh J, Ind J Exp Biol, (1996) (communicated)
9. Atal CK, Dubey RK.& Singh J J Pharmacol Exp Therap, 232 (1985) 258.
10. Reen RK, Janwal DS, Taneja SC, Koul J L, Dubey RK, Wiebel FJ & Singh J, Biochem Pharmacol, 46 (1993) 229.
11. Kamath SA and Rubin E, Biochem Biophys Res Commun, 49 (1972) 52.
12. Singh J, Schwarz LR & Wiebel FJ, Biochem J, 189 (1980) 369.
13. Tietze F, Analyt Biochem, 27 (1969) 502.
14. Hissn PJ & Hilff R, Analyt Biochem, 74 (1976) 214.
15. Yagi K, Methods in Enzymol, 105 (1984) 328.
16. Reitman S & Frankel S, Am J Clin Pathol, 28 (1957) 56.
17. Moldeus P, Biochem Pharmacol, 27 (1978) 2859.
18. Lowry OH, Rosebrough NJ, Farr AL & Randall RJ, J Biol Chem, 193 (1951) 265.
19. Blaauboer B.J.In: Hepatocyte-based in vitro models and their application in pharmaco-toxicology, EC Meeting.Brussels Belgium, Jan.23-23, 1995, p. 1.
20. Orrenius S, Thor H & Jernstrom B, In: Environmental Chemicals-Enzyme function and human diseases. Ciba Foundation Symposium, Excerpta Medica, Amsterdam, 1980, vol.76, p.25.
21. Biasi F, Albano E, Chiarpotto E, Corongiu FP, Pronatzo MA, Marinari UM, Parola M, Dianzani MU & Poli G, Cell Biochem Function, 9 (1991) 111.
22. Lauriault UV, Khem S & O' Brien PJ, Chem Biol Interact, 81 (1992) 271.
23. Vermeulen NPE, Bessems JGM & Van De Straat R, Drug Metab Rev, 24 (1992) 367.
24. Lindros KO, Cai Y & Pentilla K E, Hepatology, 12 (1990) 1092.
25. Koop DR. & Tierney DJ, Bioassays, 12 (1990) 429.
26. Rauen VHM & Schriewer H, Arzeneimittel Forsch, 21 (1971) 1194.
27. Flory PJ, Krug G, Lorenz D & Mennicke WH, Planta Med, 38 (1980) 227.
28. Hargreaves T & Piper RF, In: New trends in the therapy of liver diseases, Int Symp Tirrenia 1974 (Ed. Aldo Bertelli Pisa), Kargel Basel, 1975, p. 154.